Waters SVP Conly reports 6,030 shares and stock units
The reported common-stock amount includes unvested restricted stock units, with 2026-plan vesting scheduled through November 26, 2028.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Waters Corp's SVP, Waters Biosciences, D. Steven Conly, reported direct holdings of 6,030 shares of common stock on October 29, 2026. The reported amount comprises 339 common shares, 117 unvested restricted stock units under the 2020 Equity Incentive Plan and 5,574 unvested restricted stock units under the 2026 Equity-Based Incentive Plan.
He also reported stock appreciation rights and a stock option covering 574 common shares. The 2026-plan RSUs have vesting dates through November 26, 2028, subject to continued service; the option's first vesting installment is February 25, 2027, also subject to continued service.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Conly D Steven
Role
SVP, Waters Biosciences
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Appreciation Rights F3, F4 | -- | -- | -- |
| Holding | Stock Appreciation Rights F3, F4 | -- | -- | -- |
| Holding | Stock Appreciation Rights F3, F4 | -- | -- | -- |
| Holding | Stock Appreciation Rights F3, F4 | -- | -- | -- |
| Holding | Stock Appreciation Rights F3, F4 | -- | -- | -- |
| Holding | Stock Appreciation Rights F3, F5 | -- | -- | -- |
| Holding | Stock Appreciation Rights F3, F6 | -- | -- | -- |
| Holding | Stock Appreciation Rights F3, F7 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F8 | -- | -- | -- |
| Holding | Common Stock F1, F2 | -- | -- | -- |
Holdings:
Stock Appreciation Rights — 15,453 contracts (Direct);
Stock Option (Right to Buy) — 574 contracts (Direct);
Common Stock — 6,030 shares (Direct)
Footnotes (8)
- F1. Represents (i) 339 shares of the Issuer's common stock, (ii) 117 unvested restricted stock units ("RSUs") awarded under the Issuer's 2020 Equity Incentive Plan, and (iii) 5,574 unvested RSUs awarded under the Issuer's 2026 Equity-Based Incentive Plan in connection with the transactions set forth in that certain Agreement and Plan of Merger, dated as of July 13, 2025 (the "Merger Agreement"), by and among the Issuer, Becton, Dickinson and Company, Augusta SpinCo Corporation and Beta Merger Sub, Inc. The RSUs awarded under the 2020 Equity Incentive Plan will vest in four substantially equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- F2. (Continued from footnote 1) The RSUs awarded under the 2026 Equity-Based Incentive Plan will vest as follows: 1,529 will vest on November 26, 2026; 279 will vest on March 3, 2027; 1,624 will vest on November 26, 2027; 278 will vest on March 3, 2028; and 1,864 will vest on November 26, 2028, subject to the Reporting Person's continued service with the Issuer on each such vesting date. All RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.
- F3. These stock appreciation rights were awarded under the Issuer's 2026 Equity-Based Incentive Plan in connection with the transactions set forth in the Merger Agreement.
- F4. These stock appreciation rights are fully vested and exercisable as of the date hereof.
- F5. These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2023, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- F6. These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2024, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- F7. These stock appreciation rights vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on November 26, 2025, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- F8. The shares of common stock underlying this stock option vest and become exercisable in four substantially equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Key Figures
Direct common-stock holdings: 6,030 shares
Common shares: 339 shares
Unvested restricted stock units: 117 RSUs
+3 more
6 metrics
Direct common-stock holdings
6,030 shares
Reported October 29, 2026; includes the components described in the footnotes
Common shares
339 shares
Component of the reported direct common-stock amount
Unvested restricted stock units
117 RSUs
2020 Equity Incentive Plan
Unvested restricted stock units
5,574 RSUs
2026 Equity-Based Incentive Plan
Stock option underlying shares
574 shares
Exercise price $319.4400; expires February 25, 2036
Stock appreciation rights underlying shares
1,550 shares
Exercise price $411.8500; expires November 26, 2027
Key Terms
restricted stock units, stock appreciation rights, stock option (right to buy), vesting
4 terms
restricted stock units technical
"117 unvested restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock appreciation rights technical
"These stock appreciation rights were awarded under the Issuer's 2026 Equity-Based Incentive Plan"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
stock option (right to buy) technical
"Stock Option (Right to Buy)"
vesting technical
"will vest in four substantially equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do D. Steven Conly's WAT restricted stock units vest?
The 2020-plan RSUs vest in four substantially equal annual installments, beginning February 25, 2027. Under the 2026 plan, 1,529 vest November 26, 2026; 279 on March 3, 2027; 1,624 on November 26, 2027; 278 on March 3, 2028; and 1,864 on November 26, 2028. Each vesting date is subject to continued service.
What WAT stock option did D. Steven Conly report?
The reported stock option covers 574 common shares and has an exercise price of $319.4400. It expires February 25, 2036; its first of four substantially equal annual vesting installments is February 25, 2027, subject to continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
